Osaic Holdings
IMRX icon

Osaic Holdings’s Immuneering IMRX Stock Holding History

Osaic Holdings’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90 Buy
18
+14
+350% +$71 ﹤0.01% 7843
2026
Q1 		$21 Sell
4
-4,296
-100% -$22K ﹤0.01% 7720
2025
Q4 		$28.3K Hold
4,300
– – ﹤0.01% 5624
2025
Q3 		$30.1K Hold
4,300
– – ﹤0.01% 5652
2025
Q2 		$14.5K Buy
+4,300
New +$7.37K ﹤0.01% 5936
2024
Q2 		– Sell
-1,000
Closed -$2.89K – 7511
2024
Q1 		$2.89K Buy
+1,000
New +$5.6K ﹤0.01% 6322

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Osaic Holdings's IMRX Position: Q2 2026 in Review

Osaic Holdings increased its Immuneering (IMRX) stake by 350% in Q2 2026, buying an estimated $71 and bringing the position to 18 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #7843.

Osaic Holdings first reported a position in IMRX in Q1 2024 and has held it in 6 quarters since. The position peaked at $30.1K in Q3 2025. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Osaic Holdings held 18 shares of Immuneering worth $90 as of Q2 2026.
  • Osaic Holdings bought 14 Immuneering shares in Q2 2026, an estimated $71.
  • Immuneering made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7843 holding.
  • Osaic Holdings first reported a position in Immuneering in Q1 2024 and has held it in 6 quarters since.
  • Osaic Holdings's Immuneering position peaked at $30.1K in Q3 2025.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.